MARCO ALONSO ANDONEGUI ELGUERA



DATOS GENERALES NOMBRAMIENTOS
Nombre completo   MARCO ALONSO ANDONEGUI ELGUERA
Máximo nivel de estudios   DOCTORADO
Antigüedad académica en la UNAM   10 años

Vigente   PROFESOR ASIGNATURA B TP No Definitivo
Facultad de Ciencias
Desde 16-06-2022
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI I2023
* SNI C2020 - 2021

INFORMACIÓN DE PUBLICACIONES
Firmas  
Andonegui Elguera, Marco A. Andonegui M.A. Andonegui, MA Andonegui, Marco A. Andonegui-Elguera M.A. Andonegui-Elguera, M. A.
Andonegui-Elguera, Marco A.
ID's SCOPUS  
23990160300 57212513862
Áreas de conocimiento  
Biochemistry and molecular biology Cell biology Developmental biology Genetics and heredity Immunology
Jcs 2008 Multidisciplinary sciences Oncology Psychiatry Biochemistry
Developmental biology Genetics Genetics (clinical) Immunology and allergy Medicine (miscellaneous)
Multidisciplinary Oncology Psychiatry and mental health Spectroscopy
Coautorías con entidades de la UNAM  
  • Instituto de Investigaciones Biomédicas
  • Instituto de Biotecnología
  • Facultad de Ciencias
  • Facultad de Medicina
  • Facultad de Química
Revistas en las que ha publicado  (16):
  1. ANTICANCER RESEARCH, Grecia (2024)
  2. BRITISH JOURNAL OF CANCER, Reino Unido (2013)
  3. CANCER RESEARCH, Estados Unidos America (2019)
  4. Cell Cycle, Estados Unidos America (2016)
  5. Cell Death Discovery, (2016)
  6. CURRENT GENOMICS, (2008)
  7. CYTOGENETIC AND GENOME RESEARCH, Suiza (2016)
  8. FEBS JOURNAL, Estados Unidos America (2022)
  9. Frontiers In Cell And Developmental Biology, Suiza (2021, 2022)
  10. Frontiers in Genetics, Suiza (2022)
  11. Frontiers in Oncology, Suiza (2020)
  12. Frontiers in Psychiatry, Suiza (2021)
  13. Inflammation, Estados Unidos America (2021)
  14. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Suiza (2022)
  15. JOURNAL OF CLINICAL ONCOLOGY, Estados Unidos America (2013)
  16. SpringerPlus, Alemania (2016)


Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Rista Fuente Citas WoS Citas Scopus
1Antiproliferative and Antimigratory Activity of Poly-gallic Acid in Cancer Cell LinesCoautor: Andonegui-Elguera M.A., Hernandez-Valencia C.G., Rodriguez-Martinez G., Carriles-Perez A.M., et al.2024ANTICANCER RESEARCHWoS-id: 001207543400011
Scopus-id: 2-s2.0-85186334756
00
2Proteasome inhibition alters mitotic progression through the upregulation of centromeric alpha-Satellite RNAs2ᵒ autor: Andonegui, Marco A., Caceres-Gutierrez, Rodrigo E., Oliva-Rico, Diego A., Gonzalez-Barrios, Rodrigo, et al.2022FEBS JOURNALWoS-id: 000719874800001
Scopus-id: 2-s2.0-85119207928
22
3The Influence of Oncogenic RAS on Chemotherapy and Radiotherapy Resistance Through DNA Repair PathwaysCoautor: Andonegui M.A., Cáceres-Gutiérrez R.E., Alfaro-Mora Y., Díaz-Chávez J., et al.2022Frontiers In Cell And Developmental BiologyWoS-id: 000778427600001
Scopus-id: 2-s2.0-85127718207
712
4The Roles of Histone Post-Translational Modifications in the Formation and Function of a Mitotic Chromosome1ᵉʳ autor: Andonegui-Elguera, Marco A., Caceres-Gutierrez, Rodrigo E., Lopez-Saavedra, Alejandro, Cisneros-Soberanis, Fernanda, et al.2022INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESWoS-id: 000839094600001
Scopus-id: 2-s2.0-85136342269
44
5LncRNAs-associated to genomic instability: A barrier to cancer therapy effectiveness1ᵉʳ autor: Andonegui-Elguera, Marco A., Caceres-Gutierrez, Rodrigo E., Oliva-Rico, Diego, Diaz-Chavez, Jose, et al.2022Frontiers in GeneticsWoS-id: 000893791200001
Scopus-id: 2-s2.0-85143330236
00
6The enzymatic poly(gallic acid) reduces pro-inflammatory cytokines in vitro, a potential application in inflammatory diseases2ᵒ autor: Andonegui-Elguera M.A., Zamudio-Cuevas Y., Aparicio-Juárez A., Aguillón-Solís E., et al.2021InflammationWoS-id: 000559950500001
Scopus-id: 2-s2.0-85089446397
2230
7Genotoxicity of Marijuana in Mono-UsersCoautor: Andonegui Elguera, Marco A., Fabian-Morales, Eunice, Fernandez-Caceres, Carmen, Gudiño A., et al.2021Frontiers in PsychiatryWoS-id: 000731522100001
Scopus-id: 2-s2.0-85121974318
03
8Mitotic and DNA Damage Response Proteins: Maintaining the Genome Stability and Working for the Common Good2ᵒ autor: Andonegui-Elguera, Marco A., Luna-Maldonado, Fernando, Diaz-Chavez, Jose, Herrera, Luis A.2021Frontiers In Cell And Developmental BiologyWoS-id: 000735949700001
Scopus-id: 2-s2.0-85121785224
24
9An Overview of Vasculogenic Mimicry in Breast Cancer1ᵉʳ autor: Andonegui-Elguera M.A., Alfaro-Mora Y., Cáceres-Gutiérrez R., Caro-Sánchez C.H.S., et al.2020Frontiers in OncologyWoS-id: 000524737700001
Scopus-id: 2-s2.0-85082445657
5758
10Molecular and functional characterization of alpha satellite non coding RNAs2ᵒ autor: Andonegui, Marco A., Caceres, Rodrigo E., Oliva, Diego A., Gonzalez, Rodrigo, et al.2019CANCER RESEARCHWoS-id: 000488279404304
00
11BUB1 and SURVIVIN Proteins Are Not Degraded after a Prolonged Mitosis in HCT116 Cells and Accumulate in the Nucleus1ᵉʳ autor: Andonegui-Elguera, M. A., Caceres-Gutierrez, R. E., Luna-Maldonado, F., Lopez-Saavedra, A., et al.2016CYTOGENETIC AND GENOME RESEARCHWoS-id: 000378777400103
00
12miR-125b-1 is repressed by histone modifications in breast cancer cell lines2ᵒ autor: Andonegui, Marco A., Cisneros-Soberanis, Fernanda, Herrera, Luis A.2016SpringerPlusWoS-id: 000378928000005
Scopus-id: 2-s2.0-84977074245
1817
13MAD2, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumorsCoautor: Andonegui, Marco A., Lopez-Saavedra, Alejandro, Ramirez-Otero, Miguel, Diaz-Chavez, Jose, et al.2016Cell CycleWoS-id: 000382232900020
Scopus-id: 2-s2.0-84979021077
45
14BUB1 and SURVIVIN proteins are not degraded after a prolonged mitosis and accumulate in the nuclei of HCT116 cells1ᵉʳ autor: Andonegui-Elguera, Marco A., Caceres-Gutierrez, Rodrigo E., Luna-Maldonado, Fernando, Lopez-Saavedra, Alejandro, et al.2016Cell Death DiscoveryWoS-id: 000463076300081
Scopus-id: 2-s2.0-85065080371
44
15Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumoursCoautor: Andonegui, MA, Mendoza, J, Martinez, J, Hernandez, C, et al.2013BRITISH JOURNAL OF CANCERWoS-id: 000321702400010
Scopus-id: 2-s2.0-84880262399
5151
16Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in patients with non-seminomatous testicular germ cell tumors.Coautor: Andonegui, MA, Mendoza, J, Martinez-Cedillo, J, Hernandez, CA, et al.2013JOURNAL OF CLINICAL ONCOLOGYWoS-id: 000335419601569
00
17The epigenetic origin of aneuploidyCoautor: Andonegui, MA, Herrera, LA, Prada, D, Duenas-Gonzalez, A2008CURRENT GENOMICSWoS-id: 000254654800006
Scopus-id: 2-s2.0-41549161985
5555

Capítulos de libros (WoS y Scopus)

# Título del capítulo Título del libro Autores Alcance Año ISBN Fuente
1Unraveling the Origin of Aneuploidy: Role of Epigenetic MarksAdvances In Genome Science: Keeping Up With Genome Sequence And Expression, Vol 3Prada, Diddier, Andonegui, Marco A., Herrera, Luis A., et al.Article20149781608058204WoS-id: 000439404300008

Participación en Comités de Tesis

# Título del documento Tipo de Tesis Sinodales Autores Año Entidad Url
1Alteraciones en la citocinesis como un mecanismo alternativo de toxicidad inducido por paclitaxelTesis de LicenciaturaMARCO ALONSO ANDONEGUI ELGUERA; Escobar Arrazola, Marco Armando; 2018Facultad de Ciencias,
2Regulación transcripcional de BUB1 a través del ciclo celularTesis de LicenciaturaMARCO ALONSO ANDONEGUI ELGUERA; Luna Maldonado, Fernando; 2016Facultad de Ciencias,

Descargar PDF